Indications and uses
For the management of acne. Clears up most acne blemishes, acne pimples, blackheads, and whiteheads and allows the skin to heal.
For the management of acne. Clears up most acne blemishes, acne pimples, blackheads, and whiteheads and allows the skin to heal.
Cleanse and dry skin thoroughly before applying. Cover the entire affected area with a thin layer of ThatZit 1-3 times daily. If excess dryness or peeling occurs, reduce application to once a day or every other day. Sensitivity Test for New Users: Apply ThatZit sparingly to one or two small affected areas during the first 3 times. If no discomfort occurs, follow the directions stated above.
Salicylic Acid 1%
Acne Medication
For the management of acne. Clears up most acne
blemishes, acne pimples, blackheads, and whiteheads and allows the skin to
heal.
For external use only. Using other topical acne
medications at the same time or immediately following use of this product may
increase dryness or irritation of the skin. If this occurs, only one medication
should be used unless directed by a doctor. If excessive skin irritation
develops or increases, discontinue use and consult a doctor. When using this
product avoid contact with eyes. (If contact occurs, flush thoroughly with
water).
.
If swallowed, call poison control or seek medical help.
Cleanse and dry skin thoroughly before applying. Cover the entire affected area with a thin layer of ThatZit 1-3 times daily. If excess dryness or peeling occurs, reduce application to once a day or every other day. Sensitivity Test for New Users: Apply ThatZit sparingly to one or two small affected areas during the first 3 times. If no discomfort occurs, follow the directions stated above.
Store at room temperature.
bentonite clay, capsaicin, distilled water, jojoba seed oil, peppermint oil, silver oxide, zinc oxide.
Questions? 877-4-AIDANCE
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 245199 | salicylic acid 1 % Topical Lotion | PSN | 2 |
| 1247988 | ThatZit! 1 % Topical Lotion | PSN | 2 |
| 1247988 | salicylic acid 10 MG/ML Topical Lotion [Thatzit] | SBD | 2 |
| 245199 | salicylic acid 10 MG/ML Topical Lotion | SCD | 2 |
| 245199 | salicylic acid 1 % Topical Lotion | SY | 2 |
| 1247988 | Thatzit 10 MG/ML Topical Lotion | SY | 2 |
| 1247988 | ThatZit! 1 % Topical Lotion | SY | 2 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 473d070d-1c38-488e-b991-c4d1bf45aab8 | Product name | 1 | 20210201 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 24909-401-28 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-084f-f424-e053-dadaa90a57ce | Drug Facts |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 24909-401-28 | ThatZit Acne Treatment | 28 g in 1 BOTTLE | LOTION | 28 | 2 | |
| 24909-401-28 | ThatZit Acne Treatment | 1 in 1 CARTON | LOTION | 1 | 2 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| SALICYLIC ACID | ACTIVE INGREDIENT | O414PZ4LPZ | 2 | |
| SALICYLIC ACID | ACTIVE MOIETY | O414PZ4LPZ | 2 | |
| BENTONITE | INACTIVE INGREDIENT | A3N5ZCN45C | 2 | |
| CAPSAICIN | INACTIVE INGREDIENT | S07O44R1ZM | 2 | |
| JOJOBA OIL | INACTIVE INGREDIENT | 724GKU717M | 2 | |
| PEPPERMINT OIL | INACTIVE INGREDIENT | AV092KU4JH | 2 | |
| SILVER OXIDE | INACTIVE INGREDIENT | 897WUN6G6T | 2 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 2 | |
| ZINC OXIDE | INACTIVE INGREDIENT | SOI2LOH54Z | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 24909-401 | 24909-401-28 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SALICYLIC ACID | O414PZ4LPZ | ACTIB |
| BENTONITE | A3N5ZCN45C | IACT |
| CAPSAICIN | S07O44R1ZM | IACT |
| JOJOBA OIL | 724GKU717M | IACT |
| PEPPERMINT OIL | AV092KU4JH | IACT |
| SILVER OXIDE | 897WUN6G6T | IACT |
| WATER | 059QF0KO0R | IACT |
| ZINC OXIDE | SOI2LOH54Z | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | ELIXIR / ORAL | 0.04 mg/1ml | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | CONCENTRATE / ORAL | 0.05 mg | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | SUSPENSION / ORAL | 65 mg/5ml | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | PASTE, DENTIFRICE / DENTAL | 49.3 %w/w | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | POWDER, DENTIFRICE / DENTAL | NA | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | OINTMENT / TOPICAL | 0.2 %w/w | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | GUM, CHEWING / ORAL | 526 mg | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | CAPSULE / ORAL | 60 mg | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | SPRAY, METERED / SUBLINGUAL | 1 mg | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | SOLUTION / INTRAVENOUS | 3.11 %w/v | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | INJECTION, SUSPENSION / SUBCUTANEOUS | NA | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | SUPPOSITORY / RECTAL | 375 mg | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | SUSPENSION / ORAL | 100 mg/1ml | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | FILM, SOLUBLE / BUCCAL | 3 mg | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | LOZENGE / ORAL | 12 mg | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | SHAMPOO, SUSPENSION / TOPICAL | 3.25 %w/v | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | TABLET / ORAL | 355 mg | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | GUM, CHEWING / BUCCAL | 526 mg | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | POWDER / SUBLINGUAL | 1 mg | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | FILM / BUCCAL | 12 mg | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | TABLET / ORAL | 28 mg | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | SOLUTION / ORAL | 53 mg | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | TABLET, COATED / ORAL | 1.8 mg | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | SYSTEM / TRANSDERMAL | 9.86 mg | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | SHAMPOO / TOPICAL | 0.2 %w/w | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | LOTION / TOPICAL | 16 %w/w | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | SYRUP / ORAL | 120 mg | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | POWDER, DENTIFRICE / DENTAL | 0.05 mg/mg | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | SOLUTION / DENTAL | 0.04 %v/v | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | TABLET / SUBLINGUAL | 0.15 mg | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | POWDER / TOPICAL | 0.67 mg/mg | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | SOLUTION / RESPIRATORY (INHALATION) | 3.11 %w/v | ||
| ZINC OXIDE | ZINC OXIDE | SOI2LOH54Z | INJECTION / SUBCUTANEOUS | 0.02 %w/v | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | SUPPOSITORY / VAGINAL | 288.1 mg | ||
| PEPPERMINT OIL | PEPPERMINT OIL | AV092KU4JH | TABLET, ORALLY DISINTEGRATING / ORAL | 3 mg | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | CAPSULE / ORAL | ADJ PH | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | CREAM / TOPICAL | 4.1 %w/w | ||
| BENTONITE | BENTONITE | A3N5ZCN45C | LOTION / TOPICAL | 5 %w/w |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 57e1e412-9769-4ad9-a315-0064a0c9eedc | 99a39443-98d0-47db-a6c9-e7bb4dbca9ac | 2012-09-05 | Warnings | 57e1e412-9769-4ad9-a315-0064a0c9eedc 99a39443-98d0-47db-a6c9-e7bb4dbca9ac |
Adverse event summaries are temporarily unavailable. Other product information remains available.